Company profile for BioSenic

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

BioSenic is an innovative company with the objective of addressing important unmet medical needs in the areas of innate immunity, inflammation and organ/function repair. Our expertise is focused on bone cell therapy and the therapeutic use of arsenic trioxide (As2O3). BioSenic aims to become a leading company in the field of regenerative and immune medicine by developing innovative products for bone and autoimmune and infla...
BioSenic is an innovative company with the objective of addressing important unmet medical needs in the areas of innate immunity, inflammation and organ/function repair. Our expertise is focused on bone cell therapy and the therapeutic use of arsenic trioxide (As2O3). BioSenic aims to become a leading company in the field of regenerative and immune medicine by developing innovative products for bone and autoimmune and inflammatory diseases to address many unmet medical needs.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
Belgium
Address
Address
Rue Granbonpré 11 – Bâtiment H (bte 24) 1435 Mont-St-Guibert
Telephone
Telephone
+32 493 09 73 66
Linkedin
Linkedin
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Default Event

DDL Conference

Not Confirmed

envelop Contact Supplier

DDL Conference

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.globenewswire.com/news-release/2024/10/28/2969762/0/en/BioSenic-provides-third-quarter-2024-Business-Update.html

GLOBENEWSWIRE
28 Oct 2024

https://www.globenewswire.com/news-release/2024/10/07/2958633/0/en/BioSenic-S-A-Transparency-notification-received-from-ABO-Infinium-Americas-OpCo-LTD.html

GLOBENEWSWIRE
07 Oct 2024

https://www.globenewswire.com/en/news-release/2024/09/30/2954882/0/en/BioSenic-announces-that-it-has-started-to-look-for-new-assets-the-securing-of-its-financing-for-the-coming-months-by-means-of-an-amendment-to-its-convertible-bond-contract-a-change.html

GLOBENEWSWIRE
30 Sep 2024
BioSenic reports half year 2024 results
BioSenic reports half year 2024 results

30 Sep 2024

// GLOBENEWSWIRE

https://www.globenewswire.com/en/news-release/2024/09/30/2954862/0/en/BioSenic-reports-half-year-2024-results.html

GLOBENEWSWIRE
30 Sep 2024

https://www.globenewswire.com/news-release/2024/08/19/2931869/0/en/BioSenic-S-A-Transparency-notification-received-from-ABO-Infinium-Americas-OpCo-LTD.html

GLOBENEWSWIRE
19 Aug 2024

https://www.globenewswire.com/news-release/2024/08/13/2929015/0/en/BioSenic-S-A-Transparency-notification-received-from-ABO-Infinium-Americas-OpCo-LTD.html

GLOBENEWSWIRE
13 Aug 2024

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty